Literature DB >> 33939999

Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress - not Problem.

Vishal N Rao1, Marat Fudim1, Gianluigi Savarese2, Javed Butler3.   

Abstract

Keywords:  Heart failure with reduced ejection fraction; heart failure; polypharmacy

Year:  2021        PMID： 33939999     DOI： 10.1016/j.amjmed.2021.03.038

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

Review 1.  Polypharmacy in Older Heart Failure Patients: a Multidisciplinary Approach.

Authors:  Smrithi Sukumar; Ariela R Orkaby; Janice B Schwartz; Zachary Marcum; James L Januzzi; Muthiah Vaduganathan; Haider J Warraich
Journal:  Curr Heart Fail Rep       Date:  2022-06-20

Review 2.  Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond.

Authors:  Biobelemoye Irabor; Jacqueline M McMillan; Nowell M Fine
Journal:  Front Cardiovasc Med       Date:  2022-05-17

3.  Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience.

Authors:  Bradi B Granger; James A Tulsky; Brystana G Kaufman; Robert M Clare; Kevin Anstrom; Daniel B Mark; Kimberly A Johnson; Chetan B Patel; Mona Fiuzat; Karen Steinhauser; Christopher O'connor; Joseph G Rogers; Robert J Mentz
Journal:  J Card Fail       Date:  2021-10-07       Impact factor: 6.592

Review 4.  Polypharmacy definition and prevalence in heart failure: a systematic review.

Authors:  Janine Beezer; Manal Al Hatrushi; Andy Husband; Amanj Kurdi; Paul Forsyth
Journal:  Heart Fail Rev       Date:  2021-07-02       Impact factor: 4.654
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.